Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020

dc.contributor.authorMenachemi, Nir
dc.contributor.authorYiannoutsos, Constantin T.
dc.contributor.authorDixon, Brian E.
dc.contributor.authorDuszynski, Thomas J.
dc.contributor.authorFadel, William F.
dc.contributor.authorWools-Kaloustian, Kara K.
dc.contributor.authorNeedleman, Nadia Unruh
dc.contributor.authorBox, Kristina
dc.contributor.authorCaine, Virginia
dc.contributor.authorNorwood, Connor
dc.contributor.authorWeaver, Lindsay
dc.contributor.authorHalverson, Paul K.
dc.contributor.departmentHealth Policy and Management, School of Public Healthen_US
dc.date.accessioned2020-08-05T14:41:33Z
dc.date.available2020-08-05T14:41:33Z
dc.date.issued2020-07-24
dc.description.abstractDuring April 25–29, 2020, Indiana conducted statewide random sample testing of persons aged ≥12 years to assess prevalence of active infection and presence of antibodies to SARS-CoV-2; additional nonrandom sampling was conducted in racial and ethnic minority communities to better understand the impact of the virus in certain racial and ethnic minority populations.en_US
dc.description.sponsorshipNir Menachemi reports a grant from State of Indiana which funded this study. Virginia Caine reports that she is a member of the MMWR Editorial Board. Brian E. Dixon and William F. Fadel report grants from the Indiana State Department of Health. Paul K. Halverson reports a grant from the State of Indiana. No other potential conflicts of interest were disclosed.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationMenachemi, N., Yiannoutsos, C. T., Dixon, B. E., Duszynski, T. J., Fadel, W. F., Wools-Kaloustian, K. K., Needleman, N. U., Box, K., Caine, V., Norwood, C., Weaver, L., & Halverson, P. K. (2020). Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample—Indiana, April 25–29, 2020. MMWR. Morbidity and Mortality Weekly Report, 69(29), 960–964. https://doi.org/10.15585/mmwr.mm6929e1en_US
dc.identifier.issn0149-21951545-861Xen_US
dc.identifier.urihttps://hdl.handle.net/1805/23529
dc.language.isoen_USen_US
dc.publisherDepartment of Health and Human Services, Centers for Disease Control and Preventionen_US
dc.relation.isversionof10.15585/mmwr.mm6929e1en_US
dc.relation.journalMorbidity and Mortality Weekly Reporten_US
dc.rightsPublisher Policyen_US
dc.rightsCC0 1.0 Universal*
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.sourcePublisheren_US
dc.subjectCOVID-19en_US
dc.subjectTestingen_US
dc.subjectRandom Sampleen_US
dc.subjectInfectionen_US
dc.subjectAntibodiesen_US
dc.subjectIndianaen_US
dc.titlePopulation Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Menachemi2020Population.pdf
Size:
99.32 KB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: